Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1726321
Max Phase: Preclinical
Molecular Formula: C17H18N2O2S
Molecular Weight: 314.41
Molecule Type: Small molecule
Associated Items:
ID: ALA1726321
Max Phase: Preclinical
Molecular Formula: C17H18N2O2S
Molecular Weight: 314.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccccc1)C1CCN(C(=O)c2cccs2)CC1
Standard InChI: InChI=1S/C17H18N2O2S/c20-16(18-14-5-2-1-3-6-14)13-8-10-19(11-9-13)17(21)15-7-4-12-22-15/h1-7,12-13H,8-11H2,(H,18,20)
Standard InChI Key: BVTWFNLJORBECD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 314.41 | Molecular Weight (Monoisotopic): 314.1089 | AlogP: 3.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.69 | CX LogD: 2.69 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.95 | Np Likeness Score: -2.33 |
1. PubChem BioAssay data set, |
Source(1):